India
· Delayed Price · Currency is INR Remedium Lifecare Statistics
Total Valuation
BOM:539561 has a market cap or net worth of INR 733.82 million. The enterprise value is 2.50 billion.
| Market Cap | 733.82M |
| Enterprise Value | 2.50B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:539561 has 403.20 million shares outstanding. The number of shares has increased by 70.39% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 403.20M |
| Shares Change (YoY) | +70.39% |
| Shares Change (QoQ) | -13.86% |
| Owned by Insiders (%) | 61.57% |
| Owned by Institutions (%) | 1.53% |
| Float | 136.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.07 |
| EV / Sales | 0.16 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 3.95 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -17.73% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 2.21B |
| Profits Per Employee | -29.55M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.32% in the last 52 weeks. The beta is 1.31, so BOM:539561's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | -93.32% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 6.85 |
| Relative Strength Index (RSI) | 39.16 |
| Average Volume (20 Days) | 756,587 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539561 had revenue of INR 15.49 billion and -206.84 million in losses. Loss per share was -0.40.
| Revenue | 15.49B |
| Gross Profit | -276.70M |
| Operating Income | -355.54M |
| Pretax Income | -302.11M |
| Net Income | -206.84M |
| EBITDA | -355.68M |
| EBIT | -355.54M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 51.13 million in cash and 1.81 billion in debt, giving a net cash position of -1.76 billion or -4.37 per share.
| Cash & Cash Equivalents | 51.13M |
| Total Debt | 1.81B |
| Net Cash | -1.76B |
| Net Cash Per Share | -4.37 |
| Equity (Book Value) | 458.99M |
| Book Value Per Share | 1.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -1.79%, with operating and profit margins of -2.29% and -1.33%.
| Gross Margin | -1.79% |
| Operating Margin | -2.29% |
| Pretax Margin | -1.95% |
| Profit Margin | -1.33% |
| EBITDA Margin | -2.30% |
| EBIT Margin | -2.29% |
| FCF Margin | n/a |
Dividends & Yields
BOM:539561 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -70.39% |
| Shareholder Yield | -70.39% |
| Earnings Yield | -28.19% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 5, 2024. It was a forward split with a ratio of 4.
| Last Split Date | Jul 5, 2024 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |